Yeleswaram Krishnaswamy
SEC insider (Form 3/4/5 filer). CIK 0002022156. Chief Development Officer at Rapport Therapeutics, Inc. (RAPP). 14 reported Form 4/5 transactions since Sep 2024; latest on Aug 25, 2026. Located in BOSTON, MA.
Companies Yeleswaram Krishnaswamy has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Officer, Chief Development Officer
Yeleswaram Krishnaswamy
CIK: 0002022156
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rapport Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Aug 25, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect20.8K shares at avg. $50.31$1.0M - Aug 25, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect16.2K shares at avg. $51.06$827K - Aug 24, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect13.2K shares at avg. $50.00$658K - Aug 19, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect404 shares at avg. $49.90$20K - Apr 17, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect20.2K shares at avg. $39.99$809K - Apr 14, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect10.2K shares at avg. $35.08$358K - Apr 13, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect9.2K shares at avg. $34.97$321K - Apr 10, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect500 shares at avg. $34.98$17K - Apr 8, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect360 shares at avg. $34.90$13K - Mar 25, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect10.1K shares at avg. $29.99$303K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 25, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 20,799 | $50.31 | $1,046,421 | Direct |
| Aug 25, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 16,201 | $51.06 | $827,184 | Direct |
| Aug 24, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 13,160 | $50.00 | $657,978 | Direct |
| Aug 19, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 404 | $49.90 | $20,160 | Direct |
| Apr 17, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 20,225 | $39.99 | $808,844 | Direct |
| Apr 14, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 10,200 | $35.08 | $357,797 | Direct |
| Apr 13, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 9,165 | $34.97 | $320,537 | Direct |
| Apr 10, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 500 | $34.98 | $17,490 | Direct |
| Apr 8, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 360 | $34.90 | $12,564 | Direct |
| Mar 25, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 10,115 | $29.99 | $303,355 | Direct |
1-10 of 14 transactions